The Impact of Repeated Treatment with Praziquantel of Schistosomiasis in Children under Six Years of Age Living in an Endemic Area for Schistosoma haematobium Infection

Memorias do Instituto Oswaldo Cruz

Volumn 96, Issue SUPPL., 2001, Pages 157-164

  Mduluza, T ^a   Ndhlovu, P D ^a   Madziwa, T M ^a   Midzi, N ^b   Zinyama, R ^b   Turner, C M R ^c   Chandiwana, S K ^a   Nyazema, N ^a   Hagan, P ^c  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b Blair Research Institute   (Zimbabwe)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Antibody profiles; Morbidity; Praziquantel; Schistosoma haematobium

Indexed keywords

ANTHELMINTIC AGENT; HELMINTH ANTIBODY; PARASITE ANTIGEN; PRAZIQUANTEL;

ANIMAL; ARTICLE; CHILD; ENDEMIC DISEASE; FOLLOW UP; HEMATURIA; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; RECURRENT DISEASE; RETREATMENT; SCHISTOSOMA HEMATOBIUM; TIME; ZIMBABWE;

ANIMALS; ANTHELMINTICS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CHILD; ENDEMIC DISEASES; FOLLOW-UP STUDIES; HEMATURIA; HUMANS; PRAZIQUANTEL; RECURRENCE; RETREATMENT; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; TIME FACTORS; ZIMBABWE;

EID: 0035224861     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0074-02762001000900024     Document Type: Article

References (26)

1. Butterworth AE, Bensted-Smith R, Capron A, Capron M, Dalton PR, Dunne DW, Gryzch J, Kariuki HC, Khalife J, Koech D, Mugambi M, Ouma JH, Arap-Siongok TK, Sturrock RF 1987. Immunity in human schistosomiasis mansoni. Prevention by blocking antibodies of expression of immunity in young children. Parasitology 94: 281-300.
2. Butterworth AE, Capron M, Cordingley JS, Dalton PR, Dunne DW, Kariuki HC, Kimani G, Koech D, Mugambi M, Ouma JH, Prentice MA, Richardson BA, Arap-Siongok TK, Sturrock RF, Taylor DW 1985. Immunity after treatment of human schistosomiasis mansoni. ii. Indentification of resistant individuals, and analysis of their immune responses. Tram R Soc Trop Med Hyg 79: 393-408.
3. Butterworth AE, Dalton PR, Dunne DW, Mugambi M, Ouma JH, Richardson BA, Arap Siongok TK, Sturrock RF 1984. Immunity after treatment of human schistosomiasis mansoni. I. Study Design, pre-treatment observations and the results of treatment. Trans R Soc Trop Med Hyg 78: 108-123.
4. Butterworth AE, Dunne DW, Fulford AJC, Thorne KJI, Gachuhi K, Ouma JH, Sturrock RF 1992. Human immunity to Schistosoma mansoni: observation on mechanism, and implications for control. Immunol Invest 21: 391-396.
5. Butterworth AE, Sturrock RF, Ouma JH, Mbugua GG, Fulford AJC, Kariuki HC, Koech D 1991. Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: Effects on human infection and morbidity. Parasitology 103: 339-344.
6. Demeure CE, Rihet P, Abel L, Quattara M, Bourgois A, Dessein AJ 1993. Resistance to S. mansoni in humans - Influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis 168: 1000-1008.
7. Dessein AJ, Demeure CE, Rihet P, Kohlstaedt S, Carneiro-Carvalho D, Ouattara M, Goudot-Crozel V, Dessein H, Bourgois A, Abel E, Carvallo EM, Prata A 1992. Environmental, genetic and immuniological factors in human resistance to Schistosoma mansoni. Immunol Invest 21: 423-453.
8. Grogan JE, Kremsner PG, van Dam GJ, Metzger W, Mordmuller B, Decider AM, Yazdanbakhsh M 1996. Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J Infect Dis 173.
9. Gryseels B, Nkulikyinka L, Engels D 1994. Impact of repeated community-based selective chemotherapy on morbidity due to schistosomiasis mansoni. Am J Trop Med Hyg 51: 634-641.
10. Gryseels B, Stelma F, Talla I, Polman K, Van Dam G, Sow S, Diaw M, Sturrock RF, Decam C, Niang M, Doehring-Schwerdtfeger E, Kardorff R 1995. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Trop Geo Med 46: 209-219.
11. Hagan P, Blumenthal JU, Dunn D, Simpson AJ, Wilkins HA 1991. Human IgE, IgG4 and resistance to infection with Schistosoma haematobium. Nature 349: 243-245.
12. Hagan P, Blumenthal UJ, Chaudri M, Greenwood BM, Hayes RJ, Hodgson J, Kelly C, Knight M, Simpson AJG, Smither SR, Wilkins HA 1987. Resistance to reinfection with Schistosoma haematobium in Gambian children: analysis of their immune response. Trans R Soc Trop Med Hyg 81: 938-946.
13. Hagan P, Chandiwana SK, Ndhlovu P, Woolhouse M, Dessein AJ 1994. The epidemiology, immunology and morbidity of Schistosoma haematobium infections in diverse communities in Zimbabwe. The study design. Trop Geo Med 46: 227.
14. Katz N, Chaves A, Pellegrino J 1972. A simple device of quantitative stool thick smear technique in Schistosoma mansoni. Rev Inst Med Trop Sào Paulo 14: 397-400.
15. Kloctzel K 1967. A rationale for the treatment of Schistosoma mansoni even when reinfection is expected. Trans R Soc Trop Med Hyg 61: 609-610.
16. Mott KE, Baltes R, Bambagha J, Baldassini B 1982. Field studies of the reusable polyamide filter for detection of S. haematobium eggs by urine filtration. Propernmedlizin and Parasitologie 33: 227-228.
17. Mutapi F, Ndhlovu PD, Hagan P, Spicer JT, Mduluza T, Turner CRM, Chandiwana SK, Woolhouse MEJ 1998. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. J Infec Dis 178: 289-293.
18. Ndhlovu P, Cadman H, Vennervald BJ, Christensen NO, Chidimu M, Chandiwana SK 1996. Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe. Parasite Immunol 18: 181-191.
19. Peters PA, El Alany M, Warren KS, Mahmoud FA 1980. Quick Kato smear for field quantification of S. mansoni eggs. Am J Trop Med Hyg 29: 217-219.
20. Rihet P, Demeure CE, Bourgois PA, Dessein AJ 1991. Evidence for an association between human resistance to S. mansoni and high anti-larval IgE levels. Eur J Immunol 11: 2679-2686.
21. Roberts M, Butterworth AE, Kimani G, Kamau T, Fulford AJC, Dunne DW, Ouma JH, Sturrock RF 1993. Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun 61: 4984-4993.
22. Sturrock RF, Kimani G, Cottrell BJ, Butterworth AE, Seitz HM, Siongok TK, Houba V 1983. Observations on possible immunity to reinfection among Kenyan schoolchildren after treatment for Schistosoma mansoni. Trans R Soc Trop Med Hyg 77: 33-41.
23. Webster M, Fallon PG, Fulford AJC, Butterworth AE, Ouma JH, Kimani G, Dunne DW 1997. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm. Parasite Immunol 19: 333-335.
24. Wilkins HA, Blumenthal UJ, Hagan P, Tulloch S, Hayes RJ 1987. Resistance to reinfection after treatment for urinary schistosomiasis. Trans R Soc Trop Med Hyg 81: 29-35.
25. Wilkins HA, Goll PH, Marshall TFD, Moore PJ 1984b. Dynamics of Schistosoma haematobium infection in a Gambian Community. III. Acquisition and loss of infection. Trans R Soc Trop Med Hyg 78: 227-232.
26. Woolhouse M, Taylor P, Matanhire D, Chandiwana SK 1991. Acquired immunity and epidemiology of Schistosoma haematobium. Nature 351: 757-759.